2007•Zhongguo yaofangRequires access

Cost-Effectiveness Analysis of 3 Therapeutic Schemes for Respiratory Tract Infection in Children

Xiaolin Wang

Abstract

OBJECTIVE: To compare the pharmacoeconomics outcome of 3 schemes in treating respiratory tract infection(RTI) in children.METHODS: This is a retrospective study in which a cost-effectiveness analysis were performed on the following 3 schemes in treating RTI in children: amoxicillin/potassium clavulanate(Group A),cefuroxime plus ribavirin(Group B),and cefoperazone/sulbactam(Group C).RESULTS: The costs for Group A,B and C were 855.46 yuan,798.90 yuan and 773.00 yuan,respectively;the effective rates stood at 93.75%,96.00% and 95.83%,respectively(P0.05),and the cost-effectiveness ratio were 912.5,832.2 and 806.6,respectively.CONCLUSION: Scheme C was superior among the three.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Cefuroxime, Pharmacoeconomics, Cefoperazone, Ribavirin, Amoxicillin, Internal medicine, Respiratory tract infections